GOVX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

Stats
今日成交量	141 330
平均成交量	35 726.00
市值	3.72M
EPS	$0 ( 2024-05-02 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.110
ATR14	$0.0270 (1.68%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-22	Dodd David A	Buy	8 209	Common Stock
2024-02-21	Dodd David A	Buy	520	Common Stock
2024-02-07	Reynolds Mark	Buy	2 000	Common Stock
2023-12-22	Mckee Kelly T. Jr.	Buy	6 944	Common Stock
2023-09-25	Mckee Kelly T. Jr.	Buy	9 653	Common Stock

INSIDER POWER
99.75
Last 95 transactions
Buy: 15 241 679 \| Sell: 50 000

音量相关性

長: 0.19 (neutral)

短: 0.79 (moderate)

Signal:(57.75) Neutral

GeoVax Labs, Inc. 相关性

10 最正相关
IRBT	0.975
ENNV	0.971
FWRD	0.968
MNSB	0.967
KRNY	0.967
PLL	0.967
WALD	0.962
SINT	0.962
TSLA	0.959
PRSO	0.959

10 最负相关
NVCN	-0.97
FTIV	-0.97
FLXS	-0.965
ITMR	-0.965
ROVR	-0.963
AVEO	-0.961
ADTH	-0.956
TIOAU	-0.953
MSVB	-0.952
KVSC	-0.952

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

GeoVax Labs, Inc. 相关性 - 货币/商品

0.19
( neutral )

0.12
( neutral )

0.00
( neutral )

0.18
( neutral )

0.34
( neutral )

-0.60
( weak negative )

GeoVax Labs, Inc. 财务报表

Annual	2023
营收:	$0
毛利润:	$-74 169.00 (0.00 %)
EPS:	$-14.29

FY	2023
营收:	$0
毛利润:	$-74 169.00 (0.00 %)
EPS:	$-14.29

FY	2022
营收:	$81 000.00
毛利润:	$24 716.00 (30.51 %)
EPS:	$-12.39

FY	2021
营收:	$385 000
毛利润:	$0.00 (0.00 %)
EPS:	$-3.04

Financial Reports:

No articles found.

GeoVax Labs, Inc.

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Prevention; U.S. Department of Defense; Emory University; University of Pittsburgh; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.